We are live on ! Find out more
KYTX icon

Kyverna Therapeutics
KYTX

88 hedge funds and large institutions have $108M invested in Kyverna Therapeutics in 2024 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 32 increasing their positions, 14 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,960% more call options, than puts

Call options by funds: $206K | Put options by funds: $10K

129% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 14

1.65% more ownership

Funds ownership: 65.22% → 66.88% (+1.7%)

6% less funds holding

Funds holding: 94 → 88 (-6)

18% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 28

22% less capital invested

Capital invested by funds: $138M → $108M (-$30.4M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
88
Holders Change
-6
Holders Change %
-6.38%
% of All Funds
1.16%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
23
Increased
32
Reduced
14
Closed
28
Calls
$206K
Puts
$10K
Net Calls
+$196K
Net Calls Change
+$256K

Top Buyers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$2.12M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.47M
3
UBS Group
UBS Group
Switzerland
+$935K
4
SCM
Superstring Capital Management
New York
+$873K
5
BlackRock
BlackRock
New York
+$729K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$4.49M
2
Millennium Management
Millennium Management
New York
-$2.43M
3
EC
EcoR1 Capital
California
-$2.2M
4
Franklin Resources
Franklin Resources
California
-$1.17M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$670K +$121K +25,225 +16%
RSCM
27
Rock Springs Capital Management
Maryland
$669K – – –
Charles Schwab
28
Charles Schwab
California
$635K +$15.1K +3,145 +2%
Citadel Advisors
29
Citadel Advisors
Florida
$607K +$118K +24,580 +18%
SFM
30
Sphera Funds Management
Israel
$444K -$622K -129,893 -52%
Goldman Sachs
31
Goldman Sachs
New York
$424K +$161K +33,671 +42%
TD Asset Management
32
TD Asset Management
Ontario, Canada
$338K – – –
Verition Fund Management
33
Verition Fund Management
Connecticut
$337K +$219K +45,609 +102%
Barclays
34
Barclays
United Kingdom
$335K +$93K +19,419 +28%
Two Sigma Advisers
35
Two Sigma Advisers
New York
$300K +$304K +63,390 +375%
BCM
36
Bridgeway Capital Management
Texas
$299K +$383K +80,000 New
CSS
37
Cubist Systematic Strategies
Connecticut
$196K -$79.5K -16,597 -24%
DekaBank Deutsche Girozentrale
38
DekaBank Deutsche Girozentrale
Germany
$171K – – –
Alyeska Investment Group
39
Alyeska Investment Group
Illinois
$168K – – –
BNP Paribas Financial Markets
40
BNP Paribas Financial Markets
France
$168K +$85.2K +17,786 +65%
Renaissance Technologies
41
Renaissance Technologies
New York
$167K +$214K +44,700 New
XT
42
XTX Topco
Cayman Islands
$164K -$42.4K -8,843 -17%
PCM
43
Prelude Capital Management
New York
$164K +$107K +22,367 +105%
Norges Bank
44
Norges Bank
Norway
$150K – – –
Bank of New York Mellon
45
Bank of New York Mellon
New York
$149K -$16K -3,333 -8%
Stifel Financial
46
Stifel Financial
Missouri
$147K +$188K +39,342 New
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$141K – – –
AA
48
ALPS Advisors
Colorado
$131K +$8.89K +1,856 +6%
Ohio Public Employees Retirement System (OPERS)
49
Ohio Public Employees Retirement System (OPERS)
Ohio
$125K +$160K +33,434 New
Federated Hermes
50
Federated Hermes
Pennsylvania
$120K – – –
1
2
3 4 5

KYTX Hedge Fund Activity: Q4 2024 in Review

88 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Kyverna Therapeutics (KYTX) for Q4 2024, worth a combined $108M — down 22% from $138M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of KYTX and 23 opened new positions — a net loss of 5 holders — while 14 trimmed existing stakes and 32 added.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $2.12M. The largest seller was Deerfield Management, exiting entirely with an estimated $4.49M sold.

  • 88 institutional investors held Kyverna Therapeutics (KYTX) as of Q4 2024, down from 94 in Q3 2024.
  • Funds reported $108M of Kyverna Therapeutics stock for Q4 2024, down 22% quarter-over-quarter.
  • 23 funds opened new Kyverna Therapeutics positions in Q4 2024 and 28 closed out, a net change of -5 holders.
  • The largest Kyverna Therapeutics buyer in Q4 2024 was Jacobs Levy Equity Management, an estimated $2.12M added.
  • The largest Kyverna Therapeutics seller in Q4 2024 was Deerfield Management, an estimated $4.49M sold.

Based on aggregated 13F filings for Q4 2024.